SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-041797
Filing Date
2022-04-01
Accepted
2022-04-01 16:46:35
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2210736d1_s3.htm S-3 598575
2 EXHIBIT 1.2 tm2210736d1_ex1-2.htm EX-1.2 244497
3 EXHIBIT 4.5 tm2210736d1_ex4-5.htm EX-4.5 399871
4 EXHIBIT 5.1 tm2210736d1_ex5-1.htm EX-5.1 30516
5 EXHIBIT 23.1 tm2210736d1_ex23-1.htm EX-23.1 1729
6 EX-FILING FEES tm2210736d1_ex-filingfees.htm EX-FILING FEES 28641
7 GRAPHIC tm2210736d1_s3img01.jpg GRAPHIC 7383
8 GRAPHIC tm2210736d1_s3img001.jpg GRAPHIC 9557
9 GRAPHIC tm2210736d1_s3img002.jpg GRAPHIC 7496
10 GRAPHIC tm2210736d1_ex5-1img01.jpg GRAPHIC 4483
11 GRAPHIC tm2210736d1_ex5-1img02.jpg GRAPHIC 2054
  Complete submission text file 0001104659-22-041797.txt   1348137
Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Filer) CIK: 0001710072 (see all company filings)

IRS No.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-264083 | Film No.: 22799003
SIC: 2834 Pharmaceutical Preparations